Skip to content

Philip W Gold

3 papers in the library · 64 citations · publishing 2017-2023

Papers

Sort Most recent Most cited

Inflammation, stress and depression: an exploration of ketamine’s therapeutic profile

Drug Discovery Today February 1, 2023 J. Johnston, Maximillian Greenwald, Ioline D. Henter et al. 64 citations

Well-established animal models of depression have described a proximal relationship between stress and central nervous system (CNS) inflammation – a relationship mirrored in the peripheral inflammatory biomarkers of individuals with depression. Evidence also suggests that stress-induced proinflammatory states can contribute to the neurobiology of treatment-resistant depression. Interestingly,...

The role of adipokines in the rapid antidepressant effects of ketamine.

Molecular Psychiatry January 2017 Rodrigo Machado‐Vieira, Philip W Gold, D A Luckenbaugh et al.

We previously found that body mass index (BMI) strongly predicted response to ketamine. Adipokines have a key role in metabolism (including BMI). They directly regulate inflammation and neuroplasticity pathways and also influence insulin sensitivity, bone metabolism and sympathetic outflow; all of these have been implicated in mood disorders. Here, we sought to examine the role of three key...

Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.

Journal of Psychiatric Research January 2017 Minkyung Park, Laura E Newman, Philip W Gold et al.

Several pro-inflammatory cytokines have been implicated in depression and in antidepressant response. This exploratory analysis assessed: 1) the extent to which baseline cytokine levels predicted positive antidepressant response to ketamine; 2) whether ketamine responders experienced acute changes in cytokine levels not observed in non-responders; and 3) whether ketamine lowered levels of...